Ygen L News Today : Breaking News, Live Updates & Top Stories | Vimarsana

1 March 2021 | 09:08am StockMarketWire.com - Molecular diagnostics group Yourgene Health said its secured a $1.5 million supply agreement with a large US clinical laboratory group. The agreement, spanning five years, granted the partner non-exclusive access to Yourgene's Ranger technology, gained as part of the acquisition of Coastal Genomics in August 2020. At 9:08am: [LON:YGEN] share price was 0p at 16.75p Story provided by StockMarketWire.com Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Latest share price and company details:

8 February 2021 | 07:12am StockMarketWire.com - Molecular diagnostics group Yourgene Health warned that it would fall short of its previous revenue forecasts, citing the Covid-19 pandemic's impact on ordering patterns. Revenue for the year through March was now expected in the range of £18 million-to-£20 million, lower than previous guidance but still representing year-on-year growth of around 10-20%. Yourgene Health said sales growth had been driven by its European-focused product lines in testing for cystic fibrosis, prenatal aneuploidies and DPD. However, that had been offset by a signif...

8 February 2021 | 08:43am StockMarketWire.com - UK stocks opened higher on Monday following rises on Asian exchanges and in the oil price, as a global Covid vaccine rollout gains momentum and US lawmakers close in on a stimulus deal. At 0824, the benchmark FTSE 100 index was up 18.61 points, or 0.3%, at 6,507.94. BP gained 0.9% to 254.25p and Shell was broadly flat at £13.448 after Brent crude prices hit $60 a barrel. Credit reporting company Experian reversed 1.4% to £26.01, despite stating there was no evidence its systems had been compromised following media reports about data illegally...